Regeneron/Sanofi stopped their Covid-19 therapy trial. Another CYDY competitor bites the dust. While a shame for getting a treatment for patients, t was a huge study sucking up eligible study participants for leronlimab.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
